Laboratory standards and guidelines for population-based cystic fibrosis carrier screening

Genetics in Medicine

Volumn 3, Issue 2, 2001, Pages 149-154

  Grody, Wayne W ^a   Cutting, Garry R ^a   Klinger, Katherine W ^a   Richards, Carolyn Sue ^a   Watson, Michael S ^a   Desnick, Robert J ^a  

^a American College of Medical Genetics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

CODON; CYSTIC FIBROSIS; FAMILY HISTORY; GENE MUTATION; GENETIC COUNSELING; GENETIC HETEROGENEITY; GENETIC MODEL; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOTE DETECTION; HOMOZYGOSITY; HUMAN; LABORATORY TEST; MALE GENITAL TRACT MALFORMATION; MASS SCREENING; MOLECULAR CLONING; PRACTICE GUIDELINE; PREGNANCY; PRENATAL DIAGNOSIS; PROGNOSIS; QUALITY CONTROL; REVIEW; TAY SACHS DISEASE;

EID: 0035746363     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/00125817-200103000-00010     Document Type: Review

References (26)

1. NIH Consensus Development Conference Statement. Genetic testing for cystic fibrosis. April 14-16, 1997
2. Screening for cystic fibrosis carrier state
3. Identification of the cystic fibrosis gene: Chromosome walking and jumping
4. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA
5. Identification of the cystic fibrosis gene: Genetic analysis
6. Tay-Sachs disease - Carrier screening, prenatal diagnosis, and the molecular era: An international perspective, 1970 to 1993. The International TSD Data Collection Network
7. Couple screening for cystic fibrosis
8. Active cascade testing for carriers of cystic fibrosis gene
9. Identification of common cystic fibrosis mutations in African-Americans with cystic fibrosis increases the detection rate to 75%
10. Screening for five mutations detects 97% of cystic fibrosis (CF) chromosomes and predicts a carrier frequency of 1:29 in the Jewish Ashkenazi population
11. Population variation of common cystic fibrosis mutations
12. Geographic distribution and regional origin of 272 cystic fibrosis mutations in European populations. The Biomed CF Mutation Analysis Consortium
13. Cystic fibrosis mutations: Report from the French Registry
14. Application of DNA analysis in a population-screening program for neonatal diagnosis of cystic fibrosis (CF): Comparison of screening protocols
15. Cystic fibrosis heterozygote screening in 5,161 pregnant women
16. PCR-based screening for cystic fibrosis carrier mutations in an ethnically diverse pregnant population
17. Screening for diseases frequent in the Ashkenazi Jewish population
18. Prenatal genetic carrier testing using triple disease screening
19. Complete detection of mutations in cystic fibrosis of Native American origin
20. High frequency of the R117H cystic fibrosis mutation in patients with congenital absence of the vas deferens
21. Congenital bilateral absence of the vas deferens: A primarily genital form of cystic fibrosis
22. A mutation in CFTR produces different phenotypes depending on chromosomal background
23. Distinct spectrum of CFTR gene mutations in congenital absence of vas deferens
24. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens
25. Genotyping errors with the polymerase chain reaction